Karyopharm Therapeutics Inc. (KPTI) stock
KPTINasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPTIQ
$0.04−0.01 (-20.00%)
Close on Nov 9, 2026Market cap $1.16KP/E –Yield –
Karyopharm Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Karyopharm Therapeutics's enterprise value was -$64.19M on Nov 9, 2026, against $3.01M a year earlier. Over the last 5 years it ranged from -$137.29M to $546.86M, with a median of -$17.92M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 9, 2026 | -$64.19M | -453.7% |
| 2025 | Dec 31, 2025 | $18.15M | – |
| 2024 | Dec 31, 2024 | -$48.76M | – |
| 2023 | Dec 29, 2023 | -$108.68M | -185.5% |
| 2022 | Dec 30, 2022 | $127.11M | -54.8% |
| 2021 | Dec 31, 2021 | $281.27M | -67.9% |
| 2020 | Dec 31, 2020 | $875.17M | -6.4% |
| 2019 | Dec 31, 2019 | $934.53M | +158.4% |
| 2018 | Dec 31, 2018 | $361.66M | +8.5% |
| 2017 | Dec 29, 2017 | $333.27M | +35.2% |
| 2016 | Dec 30, 2016 | $246.59M | -11.3% |
| 2015 | Dec 31, 2015 | $277.95M | -72.0% |
| 2014 | Dec 31, 2014 | $993.63M | +15268.1% |
| 2013 | Dec 31, 2013 | $6.47M | – |
See a number that looks wrong?